Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...

Bank stocks climbed on Thursday after the Federal Open Market Committee implemented a half a percentage point interest rate ...

Alibaba stock is higher Thursday after the Chinese e-commerce giant released over 100 AI models, but Wall Street was already ...

US Fed announced its first rate cut in four years last night. Cheniere CEO explains why that may be a tailwind for Cheniere ...

Metlife Inc (MET) stock saw a modest uptick, ending the day at $79.25 which represents a slight increase of $0.97 or 1.24% from the prior close of $78.28. The stock opened at $78.56 and touched a low ...

Here are our picks for this week: Trent Butler - Westside. Jay Jefferies - Westside. Ben Parsons - Aquinas. The Fightin' ...

At the same time, jobless claims, a measure of layoffs, have remained low. The Federal Reserve made a sizable half-percentage-point cut in its policy interest rate on Wednesday, in part to keep the ...

Some have blamed the lull in rates on terminal fees eating into freight earnings, but Jefferies analyst Omar Nokta said those ...

We recently compiled a list of the 20 Trending AI Stocks on Latest News and Analyst Ratings. In this article, we are going to ...

Fintel reports that on September 18, 2024, Jefferies downgraded their outlook for Edwards Lifesciences (NYSE:EW) from Buy to ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial public offering in the United States, according to a regulatory filing.

The Federal Reserve's big interest-rate reduction on Wednesday came as a surprise to many, considering the data-dependent central bank didn't seem to have a whole lot of data to back up its decision.